drugset / Trial / NCT05386186
The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
Phase 4
Unknown
192 enrolled
Peking University People's Hospital
Jiangsu Province Geriatric Institute · collabPeking University First Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the trial is to verify the effectiveness and safety of glimepiride compared with sitagliptin as an add-on therapy to metformin in severe insulin deficiency diabetes.
Timeline
- Start
- 2022-01-01
- Primary completion
- 2023-10-31
- Completion
- 2024-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | 1 mg | — |
| Subject | Glimepiride | Small molecule | 4 mg | — |
| Subject | Glimepiride | Small molecule | 6 mg | — |
| Comparator | Sitagliptin | Small molecule | 100 mg | — |